APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Lyme Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Veterinary Lyme Disease Vaccine Industry Growth and Trends Forecast to 2032

27 December 202591 pages

Choose your research edition.

Industry ResearchVeterinary Lyme Disease Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Lyme Disease Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Veterinary Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Lyme Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Lyme Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Lyme Disease Vaccine include Bioveta, Zoetis, Boehringer Ingelheim, Elanco and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary Lyme Disease Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Lyme Disease Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Lyme Disease Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Lyme Disease Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Lyme Disease Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Lyme Disease Vaccine Market by Company

Bioveta

Zoetis

Boehringer Ingelheim

Elanco

Merck

Veterinary Lyme Disease Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Veterinary Lyme Disease Vaccine Segment by Application

Canine

Feline

Others

Veterinary Lyme Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Lyme Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Lyme Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Lyme Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Lyme Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Lyme Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monovalent Vaccines Table 2. Major Company of Combination Vaccines Table 3. Global Veterinary Lyme Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Veterinary Lyme Disease Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Veterinary Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Veterinary Lyme Disease Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Veterinary Lyme Disease Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Veterinary Lyme Disease Vaccine Industry Trends Table 25. Veterinary Lyme Disease Vaccine Industry Drivers Table 26. Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges Table 27. Veterinary Lyme Disease Vaccine Industry Restraints Table 28. Global Veterinary Lyme Disease Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Veterinary Lyme Disease Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Veterinary Lyme Disease Vaccine Sales Share by Company (2021-2026) Table 32. Global Veterinary Lyme Disease Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Veterinary Lyme Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Veterinary Lyme Disease Vaccine Major Company Production Sites and Headquarters Table 35. Global Veterinary Lyme Disease Vaccine Company, Product Type & Application Table 36. Global Veterinary Lyme Disease Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Veterinary Lyme Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Veterinary Lyme Disease Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Veterinary Lyme Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Veterinary Lyme Disease Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Veterinary Lyme Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Veterinary Lyme Disease Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Veterinary Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Veterinary Lyme Disease Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Veterinary Lyme Disease Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bioveta Company Information Table 72. Bioveta Business Overview Table 73. Bioveta Veterinary Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bioveta Veterinary Lyme Disease Vaccine Product Portfolio Table 75. Bioveta Recent Development Table 76. Zoetis Company Information Table 77. Zoetis Business Overview Table 78. Zoetis Veterinary Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zoetis Veterinary Lyme Disease Vaccine Product Portfolio Table 80. Zoetis Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Elanco Company Information Table 87. Elanco Business Overview Table 88. Elanco Veterinary Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Elanco Veterinary Lyme Disease Vaccine Product Portfolio Table 90. Elanco Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Veterinary Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck Veterinary Lyme Disease Vaccine Product Portfolio Table 95. Merck Recent Development Table 96. North America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 98. North America Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 99. North America Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Veterinary Lyme Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Veterinary Lyme Disease Vaccine Market Share by Country (2021-2026) Table 104. North America Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Veterinary Lyme Disease Vaccine Market Share Forecast by Country (2027-2032) Table 106. Europe Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 108. Europe Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 109. Europe Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Veterinary Lyme Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Veterinary Lyme Disease Vaccine Market Share by Country (2021-2026) Table 114. Europe Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Veterinary Lyme Disease Vaccine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Veterinary Lyme Disease Vaccine Market Share by Country (2021-2026) Table 124. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Veterinary Lyme Disease Vaccine Market Share Forecast by Country (2027-2032) Table 126. Latin America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Latin America Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 129. Latin America Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Veterinary Lyme Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Veterinary Lyme Disease Vaccine Market Share by Country (2021-2026) Table 134. Latin America Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Veterinary Lyme Disease Vaccine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Veterinary Lyme Disease Vaccine Market Share by Country (2021-2026) Table 144. Middle East and Africa Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Veterinary Lyme Disease Vaccine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Veterinary Lyme Disease Vaccine Distributors List Table 149. Veterinary Lyme Disease Vaccine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Veterinary Lyme Disease Vaccine Image Figure 2. Global Veterinary Lyme Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Lyme Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Lyme Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Monovalent Vaccines Image Figure 6. Global Monovalent Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Vaccines Image Figure 8. Global Combination Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Veterinary Lyme Disease Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Veterinary Lyme Disease Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Veterinary Lyme Disease Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Canine Image Figure 24. Global Canine Sales YoY Growth (2021-2032) & (K Units) Figure 25. Feline Image Figure 26. Global Feline Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Veterinary Lyme Disease Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Veterinary Lyme Disease Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Veterinary Lyme Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Veterinary Lyme Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Veterinary Lyme Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Veterinary Lyme Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Veterinary Lyme Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Veterinary Lyme Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Veterinary Lyme Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Veterinary Lyme Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Veterinary Lyme Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Veterinary Lyme Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Veterinary Lyme Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Veterinary Lyme Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Veterinary Lyme Disease Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Veterinary Lyme Disease Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Canine
  • Feline
  • Others
Companies covered
  • Bioveta
  • Zoetis
  • Boehringer Ingelheim
  • Elanco
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Lyme Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Lyme Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Lyme Disease Vaccine Market by Type
  6. 1.3.1 Monovalent Vaccines
  7. 1.3.2 Combination Vaccines
  8. 1.4 Global Veterinary Lyme Disease Vaccine Market Size by Type
  9. 1.4.1 Global Veterinary Lyme Disease Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Veterinary Lyme Disease Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Veterinary Lyme Disease Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Veterinary Lyme Disease Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Veterinary Lyme Disease Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Veterinary Lyme Disease Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Veterinary Lyme Disease Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Lyme Disease Vaccine Industry Trends
  2. 2.2 Veterinary Lyme Disease Vaccine Industry Drivers
  3. 2.3 Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Lyme Disease Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Lyme Disease Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Lyme Disease Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Lyme Disease Vaccine Price (2021-2026)
  4. 3.4 Global Veterinary Lyme Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Lyme Disease Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Lyme Disease Vaccine Company, Product Type & Application
  7. 3.7 Global Veterinary Lyme Disease Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Lyme Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Lyme Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Lyme Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Lyme Disease Vaccine Regional Status and Outlook
  1. 4.1 Global Veterinary Lyme Disease Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Lyme Disease Vaccine Historic Market Size by Region
  3. 4.2.1 Global Veterinary Lyme Disease Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Lyme Disease Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Lyme Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Lyme Disease Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Lyme Disease Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Lyme Disease Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Lyme Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Lyme Disease Vaccine by Application
  1. 5.1 Veterinary Lyme Disease Vaccine Market by Application
  2. 5.1.1 Canine
  3. 5.1.2 Feline
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Lyme Disease Vaccine Market Size by Application
  6. 5.2.1 Global Veterinary Lyme Disease Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Veterinary Lyme Disease Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Veterinary Lyme Disease Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Veterinary Lyme Disease Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Veterinary Lyme Disease Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Veterinary Lyme Disease Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Veterinary Lyme Disease Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bioveta
  2. 6.1.1 Bioveta Company Information
  3. 6.1.2 Bioveta Business Overview
  4. 6.1.3 Bioveta Veterinary Lyme Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bioveta Veterinary Lyme Disease Vaccine Product Portfolio
  6. 6.1.5 Bioveta Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Veterinary Lyme Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Veterinary Lyme Disease Vaccine Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Elanco
  20. 6.4.1 Elanco Company Information
  21. 6.4.2 Elanco Business Overview
  22. 6.4.3 Elanco Veterinary Lyme Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elanco Veterinary Lyme Disease Vaccine Product Portfolio
  24. 6.4.5 Elanco Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Veterinary Lyme Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Veterinary Lyme Disease Vaccine Product Portfolio
  30. 6.5.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Lyme Disease Vaccine Sales by Country
  2. 7.1.1 North America Veterinary Lyme Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Lyme Disease Vaccine Market Size by Country
  6. 7.2.1 North America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Lyme Disease Vaccine Sales by Country
  2. 8.1.1 Europe Veterinary Lyme Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Lyme Disease Vaccine Market Size by Country
  6. 8.2.1 Europe Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Lyme Disease Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Lyme Disease Vaccine Sales by Country
  2. 10.1.1 South America Veterinary Lyme Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Lyme Disease Vaccine Market Size by Country
  6. 10.2.1 South America Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Lyme Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Lyme Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Lyme Disease Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Lyme Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Lyme Disease Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Lyme Disease Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Lyme Disease Vaccine Value Chain Analysis
  2. 12.1.1 Veterinary Lyme Disease Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Lyme Disease Vaccine Production Mode & Process
  7. 12.2 Veterinary Lyme Disease Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Lyme Disease Vaccine Distributors
  10. 12.2.3 Veterinary Lyme Disease Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst